| Literature DB >> 33114084 |
Enrico Gugliandolo1, Roberta Fusco1, Patrizia Licata2, Alessio Filippo Peritore1, Ramona D'amico1, Marika Cordaro1, Rosalba Siracusa1, Salvatore Cuzzocrea1, Rosalia Crupi2.
Abstract
Bovine endometritis is a serious pathogen-induced infectious disease that affects the physiological processes of estrus, pregnancy and the postpartum condition. The inflamed endometrium responds by activating an inflammatory intracellular signaling cascade that leads to increased expression of proinflammatory cytokines and reactive oxygen species (ROS). Oxidative stress is closely related to several pathological conditions in perinatal dairy cows and play a key role in tissue damage. Hydroxytyrosol (HT), a natural phenolic alcohol with a strong antioxidant activity, displayed a wide range of biological effect. The aim of this study was to evaluate the protective effects of HT in an in vitro model of lipopolysaccharide (LPS)-induced inflammation in bovine uterine endometrial cells. Our results showed that HT had a significant protective effect in LPS-induced inflammation and oxidative stress. HT was also able to increase the capacity of endogenous antioxidant systems through the up-regulation of the NRF2 pathway. Furthermore, HT restored the tight junction protein expressions. In conclusion, our results showed the protective effects of HT in LPS-stimulated BEND cells. Therefore, the results of this study suggest an important protective role of HT in the treatment and prevention of uterine pathologies in dairy cows.Entities:
Keywords: bovine endometritis; endometrial epithelial cell; hydroxytyrosol
Year: 2020 PMID: 33114084 PMCID: PMC7712648 DOI: 10.3390/vetsci7040161
Source DB: PubMed Journal: Vet Sci ISSN: 2306-7381
Effects of HT on BEND cells viability.
| LPS -/HT - | |
|---|---|
|
| 100 ± 0 |
|
| 98.6 ± 0.50 |
|
| 98.4± 0.67 |
|
| 97.8 ± 0.86 |
|
| 94.6 ± 1.20# |
|
| 93.6 ± 1.56## |
#p < 0.05 vs. LPS; ## p < 0.01 vs. LPS.
Effects of HT on oxidative stress and inflammation in BEND cells stimulated with lipopolysaccharides (LPS).
| LPS -/HT - | LPS +/HT- | LPS +/HT 10 μM | LPS +/HT 25 μM | |
|---|---|---|---|---|
|
| 16.6 ± 0.02 | 33.8 ± 1.68 *** | 22.4 ± 1.20 ## | 15.6 ± 1.07 ### |
|
| 252.8 ± 10.8 | 304.8 ± 7.41 ** | 241.8 ± 5.2 # | 237 ± 7.36 ### |
|
| 1.70 ± 0.1 | 4.30 ± 120.8 ** | 1.50 ± 0.11 ## | 1.32 ± 0.16 ### |
ROS, reactive oxygen species; TNF-α, tumor necrosis factor α; IL-6, interleukin 6. ** p < 0.01 vs control; # p < 0.05 vs. LPS; ## p < 0.01 vs. LPS; *** p < 0.001 vs. control; ### p < 0.001 vs. LPS.
Figure 1HT pre-treatment on LPS-induced Nrf2 pathway in BEND cell: mRNA levels of Nrf2 (A), HO-1 (B) and NQO-1 (C). * p < 0.05 vs control; # p < 0.05 vs. LPS; ## p < 0.01 vs. LPS; *** p < 0.001 vs. control; ### p < 0.001 vs. LPS.
Figure 2HT pre-treatment on LPS-induced changes in tight junction expressions Nrf2 in BEND cell: mRNA levels of Claudin (A), CDH1 (B) and TJP1 (C). * p < 0.05 vs control; # p < 0.05 vs. LPS; ## p < 0.01 vs. LPS; ** p < 0.01 vs. control; ### p < 0.001 vs. LPS.